Utilizing the Timed Up and Go Test to Predict Five-Year Mortalities Among Older Cardiovascular Inpatients: A Prospective Cohort Study.

Rev Cardiovasc Med

Department of Cardiology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, 100730 Beijing, China.

Published: August 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: To examine the predictive value of the Timed Up and Go test (TUGT) for five-year mortality among older patients with cardiovascular disease (CVD).

Methods: This prospective cohort study was conducted at the Beijing Hospital in China from September 2018 to April 2019, with a follow-up period of 5 years. Patients underwent the TUGT at baseline and were categorized into two groups based on the subsequent results: Group 1 (TUGT >15 s) and Group 2 (TUGT ≤15 s). The primary outcome of the study was all-cause mortality over five years.

Results: The study included 491 older patients from the cardiology ward (average age 74.83 ± 6.38 years; 50.92% male). A total of 69 patients (14.05%) died over the five-year follow-up period. Patients in Group 1 were significantly older (78.36 ± 6.39 vs. 73.47 ± 5.83; < 0.001) and exhibited higher prevalence rates of heart failure (HF) (21.17% vs. 11.86%; = 0.009) and stroke or transient ischemic attack (TIA) (24.09% vs. 12.15%; = 0.001) compared to those in Group 2. After adjusting for covariates, multivariate Cox regression analysis revealed that a TUGT >15 s in CVD patients was significantly associated with an elevated hazard ratio for five-year all-cause mortality (hazard ratio (HR): 2.029; 95% confidence interval (CI): 1.198-3.437; = 0.004).

Conclusions: The TUGT is independently associated with 5-year all-cause mortality among older patients with CVD, with a TUGT >15 s indicating a poorer prognosis.

Clinical Trial Registration: ChiCTR1800017204; date of registration: 07/18/2018. URL: https://www.chictr.org.cn/showproj.html?proj=28931.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12415730PMC
http://dx.doi.org/10.31083/RCM37636DOI Listing

Publication Analysis

Top Keywords

older patients
12
tugt >15
12
all-cause mortality
12
timed test
8
prospective cohort
8
cohort study
8
mortality older
8
follow-up period
8
group tugt
8
hazard ratio
8

Similar Publications

Age-related differences in donor selection priorities for allogeneic hematopoietic transplantation.

Haematologica

September 2025

Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan; Division of Hematology, Department of Medicine, Jichi Medical University, Shimotsuke.

Patient age might influence donor selection priorities in allogeneic hematopoietic stem cell transplantation (allo-HCT), due to the differences in donor age, organ function, and resistance to graft-versus-host disease between younger and older patients. We compared the transplant outcomes among human leukocyte antigen (HLA)-matched related donors (M-RDs, n=4,106), HLA 1-antigen-mismatched related donors (1MM-RDs, n=592), HLA 2-3-antigen-mismatched related donors (23MM-RDs, n=882), HLA-matched unrelated donors (M-UDs, n=3,927), HLA 1-locus-mismatched unrelated donors (1MM-UDs, n=2,474), and unrelated cord blood units (U-CBs, n=5,867) between patients aged.

View Article and Find Full Text PDF

Aims: Chronic ocular diseases such as age-related macular degeneration (AMD) are leading causes of vision loss in older adults. While sodium-glucose co-transporter 2 inhibitors (SGLT2i) are widely prescribed in the management of type 2 diabetes mellitus (T2DM), their effects on ocular disease risk remain largely unknown.

Materials And Methods: This retrospective cohort study evaluated the association between SGLT2i use and the risk of AMD and other age-related ocular conditions in adults aged ≥60 with T2DM, using a target trial emulation framework based on the TriNetX global health research network (2013-2025).

View Article and Find Full Text PDF

Patients with traumatic injuries who develop ventilator-associated pneumonia (VAP) incur a higher risk of developing multi-drug resistance. Shorter duration of antibiotic agents for early VAP at five days may reduce antibiotic agent exposure without worsening patient outcomes. This retrospective cohort study performed at a Level I Trauma Center included adult (≥16 years old) patients with trauma diagnosed with bronchoalveolar lavage (BAL)-proven early (within four days of intubation) bacterial VAP.

View Article and Find Full Text PDF

Behind arthritis and heart disease, hearing loss (HL) is the third most prevalent chronic condition in older Americans, with primary care providers playing a crucial role in its identification. Understanding the practices and perceptions of primary care providers in hearing health is key to understanding gaps in hearing health care for patients. We conducted a quality improvement study at an urban tertiary academic facility from January–June 2024.

View Article and Find Full Text PDF

Objective: To determine the cumulative incidence of overall and cause-specific mortality among Queensland residents admitted to hospital with cirrhosis during 2007-22, by cirrhosis aetiology.

Study Design: Retrospective cohort study; analysis of linked Queensland Hospital Admitted Patient Data Collection and Queensland Registry of Births, Deaths and Marriages data.

Setting, Participants: Adult Queensland residents (18 years or older) admitted to Queensland hospitals with cirrhosis during 1 July 2007 - 31 December 2022.

View Article and Find Full Text PDF